http://grants.nih.gov/grants/policy/nihgps_2013/nihgps_ch8.htm#_Change_in_Status,

Janet,
See 8.1.2.6 of the Grant Policy Statement. Generally it is believed that a significant reduction in effort technically constitutes a change in scope. While the PI may reduce effort with the proper justification, prior approval from the program officer is required.

Best regards,

Jeanette

Jeanette Bernard- Snyder,CRA
Senior Research Administrator
Office of Sponsored Programs
University of Nevada Las Vegas
4505 Maryland Parkway
Box 451055
Las Vegas, NV 89154-1055
(702) 895-1357 Phone
(702) 895-4379 Fax
http://www.unlv.edu/research/osp

If everything seems under control, you're just not going fast enough.

Mario Andretti
US (Italian-born) automobile racer (1940 - )

.

From: "Holmberg, Janet" <xxxxxx@LRRI.ORG>
To: xxxxxx@lists.healthresearch.org,
Date: 04/23/2014 01:31 PM
Subject: [RESADM-L] Time Commitment on NIH No-cost Extensions
Sent by: Research Administration List <xxxxxx@lists.healthresearch.org>

I am doing the other support balancing act for NIH and have a question.
The PI I am working with is in the NCE year of a R21, in which his funded commitment was 15%. He is done with data collection and analysis, and this NCE year is being used to write manuscripts and write up final reports. When we reduced his time to 5% on the Other Support the GMS questioned it and said we cannot reduce time on a NCE over 25% without prior approval. I checked the grants policy guide, which says NCEs cannot have a change in scope, but says nothing about change in time commitment.
Words of wisdom from the sponsored research community?
Thanks!

Janet Holmberg
Contract Manager
LRRI/LBERI/MRN
505 348-9507 - office
505 206-7622 – mobile
505 272-8739 – office MRN (Wednesday 4/23, 4/30, 5/7)

******************************************************************************* This e-mail and any files are protected by the Electronic Communications Privacy Act, 18 U.S.C. Sections 2510-2521. Its intended to be delivered only to the named addressee(s) and its content is confidential and privileged. If you are not the intended recipient or the person responsible for delivering the e-mail to the intended recipient, be advised that you have received this e-mail in error and that any use, dissemination, forwarding, printing, or copying of this e-mail is prohibited. If you have received this e-mail in error, please notify the sender by replying to this message and delete this e-mail immediately. Nothing in this communication, either written or implied, constitutes or should be construed as a legally binding agreement between the parties with respect to the subject matter herein.

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.healthresearch.org (click on the "LISTSERV" link in the upper right corner)

A link directly to helpful tips: http://tinyurl.com/resadm-l-help ======================================================================